Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.

J Geriatr Oncol 2019 Sep 2;10(5):749-756. Epub 2019 Apr 2.

Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. Electronic address:

Objectives: We aimed to explore serum biomarkers for predicting survival of older patients with metastatic solid tumors who received first line palliative chemotherapy.

Materials And Methods: Serum samples were prospectively collected before first-line chemotherapy at 11 academic centers in Korea. All patients were participants in a prospective cohort study of older patients with metastatic solid tumors. Serum levels of C-reactive protein (CRP), CXCL10, SIRT1, VEGF-A, activin A, C-terminal telopeptide of type I collagen (CTx), total 25-hydroxyvitamin D were measured by ELISA and interleukin-6 (IL-6), myostatin, irisin, FGF-19, FGF-21, FGF-23 by Luminex multiplex assay. Overall survival (OS) was determined.

Results: Serum samples from 138 patients (median age: 75 years, range: 70-92 years) were collected from February 2014 to December 2016. During a median follow up time of 13.8 months, 73 (52.9%) patients died. Among 13 serum markers, CRP (log-rank, P = 0.009), activin A (P = 0.007), and myostatin (P = 0.047) were significantly correlated with OS in univariate analyses. Activin A (hazard ratio [HR] 2.22, 95% confidence interval [CI] 1.32-3.72; P = 0.003) and myostatin (HR 3.02, 95% CI 1.39-6.57; P = 0.005) were significantly associated with OS after adjustment for other clinical factors. In predicting early (6-month) mortality, two inflammatory markers, IL-6 and CRP, were included in the decision-tree model.

Conclusion: In older patients with cancer, high serum concentrations of activin A and myostatin were predictive of poor OS. IL-6 and CRP might be useful to select older patients at risk of early mortality. These markers could be incorporated into predictive tools for clinical decision-making and warrant further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.03.015DOI Listing
September 2019
13 Reads

Publication Analysis

Top Keywords

older patients
20
metastatic solid
12
patients metastatic
12
solid tumors
12
serum samples
8
early mortality
8
predicting survival
8
serum biomarkers
8
il-6 crp
8
biomarkers predicting
8
patients
8
serum
7
older
5
529% patients
4
138 months 529%
4
log-rank p = 0009
4
crp log-rank
4
patients died
4
serum markers
4
p = 0009 activin
4

Similar Publications